Objectives
Our rationale for introducing TXA-soaked NasoPore® to
the A&E epistaxis management pathway was to achieve the following aims.
Firstly, to reduce local epistaxis admissions, and secondly, to achieve
this in a manner which is evidence-based and maintains patient safety.
Methods